R

Renal Consultants Medical Group | RCMG Clinical Research Studies Center

Research site

(Unclaimed)

Location

16907 Devonshire Street, Granada Hills, California, United States of America

Site insights

Top conditions

Top treatments

Reloxaliase

Selonsertib

VX-147

Iron

Finerenone

Clazakizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China (RESPOND-2)

The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The mai...

Enrolling

ESRD (End-Stage Renal Disease)

Dialysis

Drug: AP301 Low Dose

Drug: AP301

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling

Atherosclerotic Cardiovascular Disease

Atherosclerotic Cardiovascular Disease in Patients With ESKD

Drug: Placebo

Drug: CSL300

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling

Proteinuric Kidney Disease

Drug: Placebo

Drug: VX-147